Cargando…

577 nm subthreshold micropulse laser treatment for acute central serous chorioretinopathy: a comparative study

BACKGROUND: To assess the efficacy of 577 nm subthreshold micropulse laser (SML) treatment for acute central serous chorioretinopathy (CSC). METHODS: This retrospective comparative case-series included 34 eyes of 34 patients with acute CSC who received either 577 nm SML treatment (SML group, n = 16...

Descripción completa

Detalles Bibliográficos
Autores principales:	Long, He, Liu, Maoxiong, Hu, Qinghua, Li, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8898420/ https://www.ncbi.nlm.nih.gov/pubmed/35248003 http://dx.doi.org/10.1186/s12886-022-02330-0

Ejemplares similares

Subthreshold 577 nm micropulse laser treatment for central serous chorioretinopathy
por: Maruko, Ichiro, et al.
Publicado: (2017)

Subthreshold micropulse yellow laser treatment for nonresolving central serous chorioretinopathy
por: Abd Elhamid, Ahmed Hosni
Publicado: (2015)

Efficacy and safety of subthreshold micropulse laser compared with threshold conventional laser in central serous chorioretinopathy
por: Sun, Zuhua, et al.
Publicado: (2019)

Role of 532 nm transfoveal subthreshold micropulse laser in non-resolving central serous chorioretinopathy with subfoveal leaks
por: Ambiya, Vikas, et al.
Publicado: (2020)

OCT biomarkers related to subthreshold micropulse laser treatment effect in central serous chorioretinopathy
por: Zheng, Fang, et al.
Publicado: (2022)

Navigated 577-nm subthreshold micropulse retinal laser treatment for peripapillary pachychoroid syndrome
por: Iovino, Claudio, et al.
Publicado: (2022)

Commentary: Subthreshold micropulse yellow laser for central serous chorioretinopathy: Finding the right protocol
por: Saurabh, Kumar, et al.
Publicado: (2022)

532-nm Subthreshold Micropulse Laser for the Treatment of Chronic Central Serous Retinopathy
por: Sousa, Keissy, et al.
Publicado: (2020)

Subthreshold micropulse laser photocoagulation versus half-dose photodynamic therapy for acute central serous chorioretinopathy
por: Zeng, Miao, et al.
Publicado: (2022)

Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser
por: Gawęcki, Maciej, et al.
Publicado: (2017)

The Short-term Efficacy of Subthreshold Micropulse Yellow (577-nm) Laser Photocoagulation for Diabetic Macular Edema
por: Kwon, Yoon Hyung, et al.
Publicado: (2014)

Subthreshold Micropulse Laser vs. Conventional Laser for Central Serous Chorioretinopathy: A Randomized Controlled Clinical Trial
por: Zhou, Lijun, et al.
Publicado: (2021)

Comparison of two protocols of subthreshold micropulse yellow laser treatment for non-resolving central serous chorioretinopathy
por: Beniwal, Abhijeet, et al.
Publicado: (2022)

Functional Outcomes and Safety Profile of Trans-Foveal Subthreshold Micropulse Laser in Persistent Central Serous Chorioretinopathy
por: Kiraly, Peter, et al.
Publicado: (2023)

Increase in Central Retinal Edema after Subthreshold Diode Micropulse Laser Treatment of Chronic Central Serous Chorioretinopathy
por: Gawęcki, Maciej
Publicado: (2015)

Subthreshold Micropulse Yellow Laser (577 nm) for Idiopathic Macular Telangiectasia Type 1 Resistant to Intravitreal Injection
por: Kang, Yong Koo, et al.
Publicado: (2020)

Diabetic Macular Edema Treated with 577-nm Subthreshold Micropulse Laser: A Real-Life, Long-Term Study
por: Frizziero, Luisa, et al.
Publicado: (2021)

Low-Fluence Photodynamic Therapy versus Subthreshold Micropulse Yellow Wavelength Laser in the Treatment of Chronic Central Serous Chorioretinopathy
por: Özmert, Emin, et al.
Publicado: (2016)

Intravitreal Dexamethasone Implant (IDI) Alone and Combined with Navigated 577 nm Subthreshold Micropulse Laser (SML) for Diabetic Macular Oedema
por: Toto, Lisa, et al.
Publicado: (2022)

Comparison of the efficacy and safety of subthreshold micropulse laser with photodynamic therapy for the treatment of chronic central serous chorioretinopathy: A meta-analysis
por: Wu, Zhizhong, et al.
Publicado: (2021)

Comparison of Subthreshold 577 and 810 nm Micropulse Laser Effects on Heat-Shock Protein Activation Kinetics: Implications for Treatment Efficacy and Safety
por: Chang, David B., et al.
Publicado: (2020)

Comparison of 532 nm Micropulse Green Laser versus Continuous-Wave 532 nm Green Laser in Chronic Central Serous Chorioretinopathy: Long-Term Follow-Up
por: Piasecka, Katarzyna, et al.
Publicado: (2020)

Morphometric analyses in patients treated with subthreshold laser photocoagulation for central serous chorioretinopathy
por: Enders, C., et al.
Publicado: (2022)

Intravitreal injections with anti-VEGF agent aflibercept versus subthreshold micropulse laser for chronic central serous chorioretinopathy: the alternative treatment regimens for verteporfin-shortage in China
por: Zhao, Tantai, et al.
Publicado: (2023)

Transfoveal Micropulse Laser Treatment of Central Serous Chorioretinopathy within Six Months of Disease Onset
por: Gawęcki, Maciej, et al.
Publicado: (2019)

Subthreshold Continuous Wave Autofluorescence-controlled Laser Treatment of Chronic Central Serous Chorioretinopathy
por: Ashraf, Hossein, et al.
Publicado: (2018)

Multifocal electroretinography-assisted anatomical and functional evaluation of subthreshold green laser in acute central serous chorioretinopathy
por: Goel, Neha, et al.
Publicado: (2021)

Comparing half-dose photodynamic therapy with high-density subthreshold micropulse laser treatment in patients with chronic central serous chorioretinopathy (the PLACE trial): study protocol for a randomized controlled trial
por: Breukink, Myrte B., et al.
Publicado: (2015)

Comparison of short-pulse subthreshold (532 nm) and infrared micropulse (810 nm) macular laser for diabetic macular edema
por: Al-Barki, Abdulrahman, et al.
Publicado: (2021)

Subthreshold laser therapy with a standardized macular treatment pattern in chronic central serous chorioretinopathy
por: Schworm, Benedikt, et al.
Publicado: (2021)

Subthreshold Micropulse Treatment Laser versus Half-Dose Photo Dynamic Therapy for the Chronic Central Serous Chorioretinopathy with Parafoveal or Subfoveal Leakage STML versus PDT for Treatment of Chronic CSC
por: Chen, Qingshan, et al.
Publicado: (2022)

Yellow Pattern 577-nm Micropulse Laser: Treatment of Macular Edema from Radiation Retinopathy – A Case Report
por: Wong, James G., et al.
Publicado: (2017)

Clinical efficacy of conbercept plus micropulse laser (577 nm) treatment in macular edema secondary to non-ischemic central retinal vein occlusion
por: Li, Li, et al.
Publicado: (2022)

Long‐term follow‐up of chronic central serous chorioretinopathy after successful treatment with photodynamic therapy or micropulse laser
por: van Rijssen, Thomas J., et al.
Publicado: (2021)

Going green – treatment outcome and safety profile of chronic central serous chorioretinopathy treated with subthreshold green laser
por: Khatri, Anadi, et al.
Publicado: (2018)

A Review of Subthreshold Micropulse Laser for Treatment of Macular Disorders
por: Scholz, Paula, et al.
Publicado: (2017)

Commentary: Subthreshold micropulse yellow laser in diabetic macular edema
por: Bansal, Mayank
Publicado: (2020)

Subthreshold Micropulse Laser for Diabetic Macular Edema: A Review
por: Sabal, Barbara, et al.
Publicado: (2022)

Central Serous Chorioretinopathy: Treatment with Laser
por: Battaglia Parodi, Maurizio, et al.
Publicado: (2020)

Micropulse Laser Trabeculoplasty with 577 nm Wavelength at 1500 or 1000 mW for Primary Open-Angle Glaucoma: A Pilot Study
por: Verdina, Tommaso, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_fcj22eknu1bddjl1k6360765d8